ULBI ULTRALIFE CORP

Nasdaq Miscellaneous Electrical Machinery, Equipment & Supplies DE CIK: 0000875657
AI RATING
SELL
78% Confidence

Investment Thesis

Ultralife Corp is fundamentally unprofitable with flat revenue growth and negative operating margins, indicating core business weakness. Despite positive free cash flow and reasonable liquidity, the company's inability to cover interest expense from operations and deteriorating EPS signal deteriorating financial health. Without revenue growth or a clear path to operating profitability, the business faces structural challenges.

Strengths

  • + Positive free cash flow generation ($1.5M) despite operating losses
  • + Strong liquidity position with 2.56x current ratio and 1.23x quick ratio
  • + Conservative debt/equity ratio of 0.34x with adequate balance sheet cushion

Risks

  • ! Negative interest coverage ratio (-1.1x) means operating income cannot cover debt service obligations
  • ! Zero revenue growth (flat YoY) with worsening profitability indicates declining business viability
  • ! Deteriorating diluted EPS (-3.00, -192% YoY) reflects shareholder value destruction and potential continued losses

Key Metrics to Watch

Financial Metrics

Revenue
47.4M
Net Income
-451.0K
EPS (Diluted)
$-3.00
Free Cash Flow
1.5M
Total Assets
220.6M
Cash
8.9M

Profitability Ratios

Gross Margin 21.3%
Operating Margin -0.5%
Net Margin -1.0%
ROE -0.3%
ROA -0.2%
FCF Margin 3.1%

Balance Sheet & Liquidity

Current Ratio
2.56x
Quick Ratio
1.23x
Debt/Equity
0.34x
Debt/Assets
41.2%
Interest Coverage
-1.09x
Long-term Debt
44.2M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-10T07:52:49.792343 | Data as of: 2026-03-31 | Powered by Claude AI